Registry Data Instead Of Randomized Control May Accelerate HF Device Trials

Large heart failure registries will provide data that could be used in lieu of a randomized control in trials of new heart failure devices, according to participants at the annual Transcathether Cardiovascular Therapeutics HHS "Town Hall Meeting" Oct. 19

More from Archive

More from Medtech Insight